Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHI
951
DELISTED
Baker Hughes
BHI
| $61.2M | 0.02% |
1,397,023
-1,808,573
| -56% | -$78.1M |
|
952
Moody's
MCO
$83.7B
| $61.1M | 0.02% |
632,735
+39,770
| +7% | +$3.57M |
|
|
INVX
953
Innovex International
INVX
$1.8B
| $60.8M | 0.02% |
1,003,989
+10,323
| +1% | +$575K |
|
954
Microchip Technology
MCHP
$38.8B
| $60.7M | 0.02% |
2,516,960
+178,460
| +8% | +$3.97M |
|
955
Vanguard Dividend Appreciation ETF
VIG
$111B
| $60.6M | 0.02% |
746,454
-31,424
| -4% | -$2.41M |
|
956
Acuity Brands
AYI
$9.99B
| $60.6M | 0.02% |
277,975
-186,448
| -40% | -$38.5M |
|
|
PGND
957
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $60.6M | 0.02% |
2,015,472
+60,255
| +3% | +$1.71M |
|
958
Jack Henry & Associates
JKHY
$11.4B
| $60.5M | 0.02% |
715,315
+112,763
| +19% | +$9.05M |
|
959
Kaiser Aluminum
KALU
$2.48B
| $60.4M | 0.02% |
715,015
+40,268
| +6% | +$3.16M |
|
|
PLCM
960
DELISTED
POLYCOM INC
PLCM
| $60.2M | 0.02% |
5,400,810
+1,419,790
| +36% | +$14.9M |
|
961
Terreno Realty
TRNO
$7.58B
| $60.2M | 0.02% |
2,565,824
+186,619
| +8% | +$4.16M |
|
962
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.4B
| $60M | 0.02% |
228,500
-93,800
| -29% | -$22.8M |
|
963
Transocean
RIG
$5.48B
| $60M | 0.02% |
6,566,234
+4,447,668
| +210% | +$44.2M |
|
964
PUT
Biogen
BIIB
$30.9B
| $59.9M | 0.02% |
230,100
+8,900
| +4% | +$2.35M |
|
965
CALL
Salesforce
CRM
$154B
| $59.7M | 0.02% |
809,200
+196,700
| +32% | +$13.5M |
|
|
BMS
966
DELISTED
Bemis
BMS
| $59.6M | 0.02% |
1,151,889
+167,992
| +17% | +$8.1M |
|
967
PUT
Oracle
ORCL
$339B
| $59.5M | 0.02% |
1,453,200
+712,900
| +96% | +$26.4M |
|
|
PKY
968
DELISTED
Parkway, Inc.
PKY
| $59.3M | 0.02% |
3,789,870
+142,854
| +4% | +$1.98M |
|
969
Omnicom Group
OMC
$23.5B
| $59.3M | 0.02% |
712,430
-413,493
| -37% | -$31.2M |
|
970
Regions Financial
RF
$26.4B
| $59.2M | 0.02% |
7,546,720
+2,499,452
| +50% | +$20.1M |
|
971
World Kinect Corp
WKC
$2.07B
| $59.1M | 0.02% |
1,217,038
+1,799
| +0.1% | +$77.2K |
|
|
BEAV
972
DELISTED
B/E Aerospace Inc
BEAV
| $59M | 0.02% |
1,279,925
-1,703,930
| -57% | -$72.9M |
|
|
VSA
973
VisionSys AI
VSA
$8.3M
| $59M | 0.02% |
2,183
| – | – |
|
974
Assurant
AIZ
$13.9B
| $58.8M | 0.02% |
762,687
-79,400
| -9% | -$6.03M |
|
975
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$259M
| $58.8M | 0.02% |
2
| – | – |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.